|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Cutsem E, Nordlinger B, Adam R, Köhne
CH, Pozzo C, Poston G, Ychou M and Rougier P; European Colorectal
Metastases Treatment Group: Towards a pan-European consensus on the
treatment of patients with colorectal liver metastases. Eur J
Cancer. 42:2212–2221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee WS, Yun SH, Chun HK, Lee WY, Yun HR,
Kim J, Kim K and Shim YM: Pulmonary resection for metastases from
colorectal cancer: Prognostic factors and survival. Int J
Colorectal Dis. 22:699–704. 2007. View Article : Google Scholar
|
|
4
|
Dhont L, Mascaux C and Belayew A: The
helicase-like transcription factor (HLTF) in cancer: Loss of
function or oncomorphic conversion of a tumor suppressor? Cell Mol
Life Sci. 73:129–147. 2016. View Article : Google Scholar
|
|
5
|
Poole LA and Cortez D: Functions of
SMARCAL1, ZRANB3, and HLTF in maintaining genome stability. Crit
Rev Biochem Mol Biol. 52:696–714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kile AC, Chavez DA, Bacal J, Eldirany S,
Korzhnev DM, Bezsonova I, Eichman BF and Cimprich KA: HLTF’s
ancient HIRAN domain binds 3′ DNA ends to drive replication fork
reversal. Mol Cell. 58:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taglialatela A, Alvarez S, Leuzzi G,
Sannino V, Ranjha L, Huang JW, Madubata C, Anand R, Levy B, Rabadan
R, et al: Restoration of replication fork stability in BRCA1- and
BRCA2-deficient cells by inactivation of SNF2-family fork
remodelers. Mol Cell. 68:414–430.e8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piao S, Ojha R, Rebecca VW, Samanta A, Ma
XH, Mcafee Q, Nicastri MC, Buckley M, Brown E, Winkler JD, et al:
ALDH1A1 and HLTF modulate the activity of lysosomal autophagy
inhibitors in cancer cells. Autophagy. 13:2056–2071. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Debauve G, Capouillez A, Belayew A and
Saussez S: The helicase-like transcription factor and its
implication in cancer progression. Cell Mol Life Sci. 65:591–604.
2008. View Article : Google Scholar
|
|
10
|
Tauriello DVF and Batlle E: Targeting the
microenvironment in advanced colorectal cancer. Trends Cancer.
2:495–504. 2016. View Article : Google Scholar
|
|
11
|
Drabsch Y and ten Dijke P: TGF-β
signalling and its role in cancer progression and metastasis.
Cancer Metastasis Rev. 31:553–568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Massagué J: TGFβ signalling in context.
Nat Rev Mol Cell Biol. 13:616–630. 2012. View Article : Google Scholar
|
|
13
|
Wakefield LM and Hill CS: Beyond TGFβ:
Roles of other TGFβ superfamily members in cancer. Nat Rev Cancer.
13:328–341. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L, Liu Z, Tan J, Dong H and Zhang X:
Multispectral imaging reveals hyper active TGF-β signaling in
colorectal cancer. Cancer Biol Ther. 19:105–112. 2018. View Article : Google Scholar
|
|
15
|
Fritzmann J, Morkel M, Besser D, Budczies
J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM and
Birchmeier W: A colorectal cancer expression profile that includes
transforming growth factor beta inhibitor BAMBI predicts metastatic
potential. - PubMed - NCBI. Gastroenterology. 137:165–175. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Papageorgis P, Cheng K, Ozturk S, Gong Y,
Lambert AW, Abdolmaleky HM, Zhou JR and Thiagalingam S: Smad4
inactivation promotes malignancy and drug resistance of colon
cancer. Cancer Res. 71:998–1008. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang B, Halder SK, Kashikar ND, Cho YJ,
Datta A, Gorden DL and Datta PK: Antimetastatic role of Smad4
signaling in colorectal cancer. Gastroenterology. 138:969–80.e1.
32010. View Article : Google Scholar
|
|
18
|
Rizzardi AE, Johnson AT, Vogel RI,
Pambuccian SE, Henriksen J, Skubitz AP, Metzger GJ and Schmechel
SC: Quantitative comparison of immunohistochemical staining
measured by digital image analysis versus pathologist visual
scoring. Diagn Pathol. 7:422012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Debauve G, Nonclercq D, Ribaucour F,
Wiedig M, Gerbaux C, Leo O, Laurent G, Journé F, Belayew A and
Toubeau G: Early expression of the Helicase-Like Transcription
Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced
renal carcinogenesis. Mol Cancer. 5:232006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Capouillez A, Decaestecker C, Filleul O,
Chevalier D, Coppée F, Leroy X, Belayew A and Saussez S:
Helicase-like transcription factor exhibits increased expression
and altered intracellular distribution during tumor progression in
hypopharyngeal and laryngeal squamous cell carcinomas. Virchows
Arch. 453:491–499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Capouillez A, Debauve G, Decaestecker C,
Filleul O, Chevalier D, Mortuaire G, Coppée F, Leroy X, Belayew A
and Saussez S: The helicase-like transcription factor is a strong
predictor of recurrence in hypopharyngeal but not in laryngeal
squamous cell carcinomas. Histopathology. 55:77–90. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye C, Sun NX, Ma Y, Zhao Q, Zhang Q, Xu C,
Wang SB, Sun SH, Wang F and Li W: MicroRNA-145 contributes to
enhancing radiosensitivity of cervical cancer cells. FEBS Lett.
589:702–709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arcolia V, Paci P, Dhont L, Chantrain G,
Sirtaine N, Decaestecker C, Remmelink M, Belayew A and Saussez S:
Helicase-like transcription factor: A new marker of
well-differentiated thyroid cancers. BMC Cancer. 14:4922014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim JJ, Chung SW, Kim JH, Kim JW, Oh JS,
Kim S, Song SY, Park J and Kim DH: Promoter methylation of
helicase-like transcription factor is associated with the early
stages of gastric cancer with family history. Ann Oncol.
17:657–662. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sandhu S, Wu X, Nabi Z, Rastegar M, Kung
S, Mai S and Ding H: Loss of HLTF function promotes intestinal
carcinogenesis. Mol Cancer. 11:182012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hibi K, Nakayama H, Kanyama Y, Kodera Y,
Ito K, Akiyama S and Nakao A: Methylation pattern of HLTF gene in
digestive tract cancers. Int J Cancer. 104:433–436. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Borinstein SC, Conerly M, Dzieciatkowski
S, Biswas S, Washington MK, Trobridge P, Henikoff S and Grady WM:
Aberrant DNA methylation occurs in colon neoplasms arising in the
azoxymethane colon cancer model. Mol Carcinog. 49:94–103. 2010.
|
|
29
|
Moinova HR, Chen WD, Shen L, Smiraglia D,
Olechnowicz J, Ravi L, Kasturi L, Myeroff L, Plass C, Parsons R, et
al: HLTF gene silencing in human colon cancer. Proc Natl Acad Sci
USA. 99:4562–4567. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wallner M, Herbst A, Behrens A, Crispin A,
Stieber P, Göke B, Lamerz R and Kolligs FT: Methylation of serum
DNA is an independent prognostic marker in colorectal cancer. Clin
Cancer Res. 12:7347–7352. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leung WK, To KF, Man EP, Chan MW, Bai AH,
Hui AJ, Chan FK and Sung JJ: Quantitative detection of promoter
hypermethylation in multiple genes in the serum of patients with
colorectal cancer. Am J Gastroenterol. 100:2274–2279. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Herbst A, Rahmig K, Stieber P, Philipp A,
Jung A, Ofner A, Crispin A, Neumann J, Lamerz R and Kolligs FT:
Methylation of NEUROG1 in serum is a sensitive marker for the
detection of early colorectal cancer. Am J Gastroenterol.
106:1110–1118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Philipp AB, Stieber P, Nagel D, Neumann J,
Spelsberg F, Jung A, Lamerz R, Herbst A and Kolligs FT: Prognostic
role of methylated free circulating DNA in colorectal cancer. Int J
Cancer. 131:2308–2319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng CK, Chan NP, Wan TS, Lam LY, Cheung
CH, Wong TH, Ip RK, Wong RS and Ng MH: Helicase-like transcription
factor is a RUNX1 target whose downregulation promotes genomic
instability and correlates with complex cytogenetic features in
acute myeloid leukemia. Haematologica. 101:448–457. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Caliskan C, Guler N, Karaca C, Makay O,
Firat O and Korkut MA: Negative prognostic factors in colorectal
carcinoma: An analysis of 448 patients. Indian J Surg. 72:243–248.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bosch SL, Teerenstra S, de Wilt JH,
Cunningham C and Nagtegaal ID: Predicting lymph node metastasis in
pT1 colorectal cancer: A systematic review of risk factors
providing rationale for therapy decisions. Endoscopy. 45:827–834.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Leake I: Colorectal cancer. Understanding
the routes of metastasis in colorectal cancer. Nat Rev
Gastroenterol Hepatol. 11:2702014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Helmer RA, Foreman O, Dertien JS, Panchoo
M, Bhakta SM and Chilton BS: Role of helicase-like transcription
factor (hltf) in the G2/m transition and apoptosis in brain. PLoS
One. 8:e667992013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang D, Sun W, Zhou Y, Li P, Chen F, Chen
H, Xia D, Xu E, Lai M, Wu Y, et al: Mutations of key driver genes
in colorectal cancer progression and metastasis. Cancer Metastasis
Rev. 37:173–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chandrasinghe P, Cereser B, Moorghen M, Al
Bakir I, Tabassum N, Hart A, Stebbing J and Warusavitarne J: Role
of SMAD proteins in colitis-associated cancer: From known to the
unknown. Oncogene. 37:1–7. 2018. View Article : Google Scholar
|
|
41
|
Xu Y and Pasche B: TGF-β signaling
alterations and susceptibility to colorectal cancer. Hum Mol Genet.
16R:R14–R20. 2007. View Article : Google Scholar
|
|
42
|
Coates RF, Gardner JA, Gao Y, Cortright
VM, Mitchell JM, Ashikaga T, Skelly J and Yang MX: Significance of
positive and inhibitory regulators in the TGF-β signaling pathway
in colorectal cancers. Hum Pathol. 66:34–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Itatani Y, Kawada K, Fujishita T, Kakizaki
F, Hirai H, Matsumoto T, Iwamoto M, Inamoto S, Hatano E, Hasegawa
S, et al: Loss of SMAD4 from colorectal cancer cells promotes CCL15
expression to recruit CCR1+ myeloid cells and facilitate
liver metastasis. Gastroenterology. 145:1064–1075.e11. 2013.
View Article : Google Scholar
|
|
44
|
Voorneveld PW, Kodach LL, Jacobs RJ, Liv
N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes
DW, de Rooij K, et al: Loss of SMAD4 alters BMP signaling to
promote colorectal cancer cell metastasis via activation of Rho and
ROCK. Gastroenterology. 147:196–208.e13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Isaksson-Mettävainio M, Palmqvist R,
Dahlin AM, Van Guelpen B, Rutegård J, Öberg A and Henriksson ML:
High SMAD4 levels appear in microsatellite instability and
hyper-methylated colon cancers, and indicate a better prognosis.
Int J Cancer. 131:779–788. 2012. View Article : Google Scholar
|
